updated 6/13/2011 8:16:57 AM ET 2011-06-13T12:16:57

HAIFA, Israel, June 13, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that according to the TASE announcement, its ordinary shares will be added to the Mid-Cap-50 Index on the TASE, beginning on June 15, 2011. The Mid-Cap-50 Index includes the 50 shares with the highest market capitalization that are not included in the TA-100 index.

Following the inclusion in the Mid-Cap-50 the company's ordinary shares will be included in the following TASE equity indexes: Biomed Index, Mid-Cap-50 TA Index, TA BlueTech-50 Index, TA Composite Index, Shares Index and the Industry Index. 

About Pluistem Therapeutics Inc.

For more information about Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) visit www.pluristem.com , the content of which is not part of this press release. Follow Pluristem on Twitter @Pluristem.

The Pluristem Therapeutics Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6882

CONTACT: Pluristem Therapeutics Inc.
         William Prather R.Ph., M.D., Sr. VP Corporate Development
         Daya Lettvin
         Director Investor & Media Relations
         Media Contact:
         Matthew Krieger
         Ruder Finn - for Pluristem

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com